Literature DB >> 20579221

Knockdown of hTERT by SiRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2.

Ying Qiang Zhong1, Zhong Sheng Xia, Yu Ru Fu, Zhao Hua Zhu.   

Abstract

OBJECTIVE: To investigate the effects of human telomerase reverse transcriptase (hTERT) on the growth of Capan-2 human pancreatic cancer cell and apoptosis.
METHODS: Cell proliferation, apoptosis and cell cycle were analyzed by cell counting and flow cytometry. mRNA and protein expressions of hTERT, Bcl-2 and cyclooxygenase (COX)-2 were assessed by real time PCR and Western blot.
RESULTS: Cell growth was significantly inhibited by 26.39 percent 24 h after hTERT-small interference RNA (siRNA) transfection (50 nmol/L) with a 100 percent silencing efficiency (P < 0.05). The inhibition rates of cell proliferation were 46.77 percent, 70.61 percent, 84.71 percent and 85.99 percent at 2, 3, 5 and 7 days after transfection, respectively (P < 0.001). Early and late apoptotic cells increased significantly (especially 24 h after transfection) (P < 0.001). The cell cycle was suppressed significantly as manifested by the increase of cells in the G0/G1 phase and the decrease of cells in the S phase and G2/M phase (P < 0.01). The expressions of Bcl-2 mRNA and COX-2 mRNA were inhibited significantly 48 h after transfection: the inhibition rates were 86.86 percent and 100 percent, respectively (P < 0.001). Levels of Bcl-2 protein were downregulated by 58.54 percent and 63.44 percent and the levels of COX-2 protein were downregulated by 50.06 percent and 82.77 percent at 48 h and 72 h after transfection, respectively.
CONCLUSION: Knockdown of hTERT by siRNA can inhibit the growth of Capan-2 cell. The inhibitory effect is associated with the downregulation of Bcl-2 and COX-2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579221     DOI: 10.1111/j.1751-2980.2010.00433.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  10 in total

Review 1.  Gene therapy in pancreatic cancer.

Authors:  Si-Xue Liu; Zhong-Sheng Xia; Ying-Qiang Zhong
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 2.  Current translational and clinical practices in hematopoietic cell and gene therapy.

Authors:  David L Digiusto; Hans-Peter Kiem
Journal:  Cytotherapy       Date:  2012-08       Impact factor: 5.414

3.  Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line.

Authors:  Yan Liang; Xiangyong Li; Rongwen Lin; Xin Zhang; Huimin Wang; Ning Tan; Keshen Li; Xudong Tang; Keyuan Zhou; Tao Li
Journal:  Biomed Rep       Date:  2012-11-09

4.  The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.

Authors:  Yingqiang Zhong; Zhongsheng Xia; Juan Liu; Ying Lin; Hui Zan
Journal:  Oncol Rep       Date:  2011-12-19       Impact factor: 3.906

Review 5.  Telomerase and drug resistance in cancer.

Authors:  Natalia Lipinska; Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Toton; Przemyslaw Kopczynski; Blazej Rubis
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

6.  hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification.

Authors:  Wojciech Barczak; Agnieszka Sobecka; Pawel Golusinski; Michal M Masternak; Blazej Rubis; Wiktoria M Suchorska; Wojciech Golusinski
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

7.  Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis.

Authors:  Georgios D Ayiomamitis; George Notas; Thivi Vasilakaki; Aikaterini Tsavari; Styliani Vederaki; Theodosis Theodosopoulos; Elias Kouroumalis; Apostolos Zaravinos
Journal:  Cancers (Basel)       Date:  2019-10-11       Impact factor: 6.639

8.  hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.

Authors:  Aleksandra Romaniuk-Drapała; Ewa Totoń; Natalia Konieczna; Marta Machnik; Wojciech Barczak; Dagmar Kowal; Przemysław Kopczyński; Mariusz Kaczmarek; Błażej Rubiś
Journal:  Cells       Date:  2021-04-10       Impact factor: 6.600

9.  Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.

Authors:  Sheeja Aravindan; Caroline R Delma; Somasundaram S Thirugnanasambandan; Terence S Herman; Natarajan Aravindan
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 10.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.